Shares of Sarepta Therapeutics Inc (NASDAQ:SRPT) ended Thursday session in green amid volatile trading. The shares closed up +4.75 points or 8.45% at $60.97 with 11.20 million shares getting traded. Post opening the session at $56.90, the shares hit an intraday low of $56.90 and an intraday high of $61.60 and the price vacillated in this range throughout the day. The company has a market cap of $2.95 billion and the numbers of outstanding shares have been calculated to be 47.90 million shares.
Sarepta Therapeutics Inc (SRPT) on September 23, 2016 announced that it has priced an underwritten public offering of an aggregate of 5.02 million shares of its common stock at a price to the public of $59.75 per share. In addition, Sarepta has granted the underwriters a 30-day option to purchase up to an additional 753,138 shares of common stock on the same terms and conditions as the initial shares sold to the underwriters. Sarepta anticipates the gross proceeds from the offering, before deducting the underwriter discounts and commissions and other offering expenses, to be approximately $300 million, excluding any exercise of the underwriters’ option to purchase additional shares. The offering is expected to close on or about September 28, 2016, subject to customary closing conditions.
Shares of Cooper Companies Inc (NYSE:COO) ended Thursday session in red amid volatile trading. The shares closed down -1.68 points or 0.90% at $184.50 with 10.84 million shares getting traded. Post opening the session at $186.75, the shares hit an intraday low of $183.64 and an intraday high of $187.09 and the price vacillated in this range throughout the day. The company has a market cap of $8.98 billion and the numbers of outstanding shares have been calculated to be 48.74 million shares.
Cooper Companies Inc (COO) on Sept. 01, 2016 announced that Gregory W. Matz, senior vice president, chief financial officer and chief risk officer, plans to retire from the company in early 2017 after more than six years of service to the company. As part of his planned transition, Mr. Matz intends to remain in his current role through fiscal year end October 31, 2016, and then act in an advisory capacity until March 2017 to ensure a smooth transition. Albert G. White, III will succeed Mr. Matz as chief financial officer, effective November 1, 2016. Mr. White will assume this role in addition to his current responsibilities as executive vice president and chief strategy officer of Cooper Companies, which includes responsibility for leading CooperSurgical.
“Greg has played a key role in helping Cooper deliver meaningful returns to our shareholders. On behalf of our Company, I want to thank him for his service and wish him the best in his retirement and future endeavors,” said Robert S. Weiss, Cooper’s president and chief executive officer.
Weiss added, “Al is a true professional with deep knowledge of the Cooper business built since joining the Company in 2006. He has excelled in key leadership positions at Cooper including leading CooperSurgical, strategy, treasury, IR, and communications. He also worked closely with Cooper in a banking capacity for many years prior to joining the company. I am highly confident in Al’s leadership and capabilities required for this expanded role.”